SHP INHIBITOR COMPOSITIONS AND USES FOR CHIMERIC ANTIGEN RECEPTOR THERAPY

COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS

ANTI-CCR8 ANTIBODIES AND USES THEREOF

MULTIFUNCTIONAL RECOMBINANT ANTIBODY, PREPARATION METHOD AND USE THEREOF

LOW PH PHARMACEUTICAL COMPOSITION COMPRISING T CELL ENGAGING ANTIBODY CONSTRUCTS

BISPECIFIC ANTIBODY

BISPECIFIC ANTIBODY CONTAINING ANTI-CLDN18.2 ANTIBODY, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

NOVEL ANTI-GPRC5D ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND GPRC5D AND CD3, AND USES THEREOF

ANTIBODIES THAT BIND INTERLEUKIN 13 AND METHODS OF USE

ANTI-MESOTHELIN ANTIBODIES

MODIFIED IMMUNOGLOBULINS FOR TARGETING AMYLOID DEPOSITS

ACUTE TREATMENT AND RAPID TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES

TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES

ANTI-O2 ANTIBODIES AND USES THEREOF

MULTISPECIFIC ANTIBODIES TARGETING MULTIPLE EPITOPES ON THE HIV-1 ENVELOPE

DOSAGE REGIMEN FOR A COMBINATION THERAPY CONSISTING OFTCR-ENGINEERED T-CELLS IN COMBINATION WITH A PD-1 AXIS BINDING ANTAGONIST

COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR

CD38 MODULATING ANTIBODY AGENTS

METHODS OF TREATING PANCREATIC CANCER WITH A PD-1 AXIS BINDING ANTAGONIST AND AN RNA VACCINE

Enhancement Of CD47 Blockade Therapy With Anti-VEGF Agents

COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH

IGM ANTIBODIES DEGRADING IGG

ANTIGEN BINDING PROTEINS

ANTIBODIES TO MUCIN-16 AND METHODS OF USE THEREOF

ANTI-CEACAM5 ANTIBODIES AND USES THEREOF

BISPECIFIC ANTIBODY TARGETING EMR2 (CD312) AND THE T-CELL RECEPTOR TRBV19

CD39/CD73 BISPECIFIC ANTIGEN BINDING PROTEIN AND USE THEREOF

FC BINDING FRAGMENTS COMPRISING AN OX40 ANTIGEN-BINDING SITE

ANTI-TNF-LIKE LIGAND 1A (TL1A) ANTIBODIES

ANTITUMOR IMMUNE CHECKPOINT REGULATOR ANTAGONISTS

PD-1 AND PD-L1 BINDING AGENTS

PROTEASE CLEAVABLE RECOMBINANT BISPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF

NOVEL ANTI-LILRB4 ANTIBODIES AND USES THEREOF

ANTIBODY/T-CELL RECEPTOR CHIMERIC CONSTRUCTS AND USES THEREOF

New Interleukin-7 Immunoconjugates

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF

USE OF GLUTAMATE MODULATING AGENTS WITH IMMUNOTHERAPIES TO TREAT CANCER

ANTI-VISTA ANTIBODIES AND FRAGMENTS

ADENO-ASSOCIATED VIRUS (AAV) DELIVERY OF ANTI-FAM19A5 ANTIBODIES

SIALIDASE FUSION MOLECULES AND RELATED USES

ANTIBODIES AND ANTIBODY FRAGMENTS THAT BIND IGE

CORONAVIRUS-INHIBITING ANTIBODIES

ANTI-CD84 ANTIBODIES AND USES THEREOF

Antibodies Against TL1A and Uses Thereof

TREATMENT OF ATOPIC DERMATITIS

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

ANTIBODIES TO GALECTIN-3 AND METHODS OF USE THEREOF

FcRn-Binding Polypeptides and Uses Thereof

MULTISPECIFIC BINDING AGENTS THAT TARGET B7H3 AND GD2 AND USES THEREOF

COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS

Preventative Agent or Therapeutic Agent for Amyotrophic Lateral Sclerosis, Parkinson's Disease, Huntington's Disease, Spinocerebellar Ataxia, Aging-Related Degenerative or Neurological Disease, Brain Aging, or Diseases Associated With Brain Aging

Bovine Preputial Epithelium Produces Antibodies Against Tritrichomonas foetus following Aerosol Application of Synthetic mRNA

ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES AND METHOD OF USE THEREOF

Cell

BLOOD-NERVE BARRIER TARGETING CONJUGATES AND METHODS OF USE

COMBINATION THERAPY USING ANTIBODY-DRUG CONJUGATES

ENGINEERED VIRUS

IL-13 ANTIBODIES FOR THE TREATMENT OF ATOPIC DERMATITIS

Improved Therapeutic Index of Anti-Immune Checkpoint Inhibitors Using Combination Therapy Comprising A PHY906 Extract, A Scutellaria baicalensis Georgi (S) Extract or A Compound From Such Extracts

THERAPEUTIC FOR CANCER REFRACTORY TO IMMUNE CHECKPOINT INHIBITOR

BINDING MOLECULES FOR BCMA AND CD3

METHODS OF TREATING CORONARY ARTERY DISEASE

T CELL BINDING PROTEINS

OX40 Binding Proteins for Cancer Regulation

ANTIBODY MOLECULES

ANTI-FCRN ANTIBODIES

ANTI-PD-L1 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)

DUAL SPECIFIC ANTIBODIES

ANTI-AP2 ANTIBODIES AND ANTIGEN BINDING AGENTS TO TREAT METABOLIC DISORDERS

METHODS FOR TREATING DIABETIC KIDNEY DISEASE AND GLOMERULAR DISEASE

COMPOUNDS USEFUL TO TREAT METABOLIC DISORDERS

ANTI-PD-L1 SINGLE-DOMAIN ANTIBODY AND DERIVATIVES AND USE THEREOF

ANTIBODY-MEDIATED CONDITIONING WITH IMMUNOSUPPRESSION TO ENABLE ALLOGENEIC TRANSPLANTATION

POLYPEPTIDES ANTAGONIZING WNT SIGNALING IN TUMOR CELLS

TREATING CHEMORESISTANT CANCERS WITH NOTCH3 INHIBITORS

IDENTIFICATION OF PATIENTS IN NEED OF PD-L1 INHIBITOR COTHERAPY

DEVELOPMENT AND VALIDATION OF AN IN VITRO METHOD FOR THE PROGNOSIS OF PATIENTS SUFFERING FROM HER2-POSITIVE BREAST CANCER

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REDUCING THE NEUROMODULATORY EFFECT OF COCAINE

HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF

Cancer Treatment comprising an anti-MSLN/CD137 antibody and a chemotherapeutic

DEVELOPMENT OF A NOVEL THERAPEUTIC CD99 ANTIBODY TO TREAT AGGRESSIVE SOLID TUMORS IN CHILDREN

ANTIBODY FC VARIANTS

BINDING PROTEIN

ANTI CD40 ANTIBODY, ANTIGEN BINDING FRAGMENT AND MEDICAL USE THEREOF

ANTI-CD30L ANTIBODIES, FORMULATIONS THEREFOR, AND USES THEREOF

THERAPEUTIC ANTIBODIES

Methods of Treating IL1RAP Associated Cancers with Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies

COMPOSITIONS AND METHODS RELATED TO RECEPTOR PAIRINGS

EPHA2-TARGETING ANTIBODIES AND THEIR APPLICATIONS IN CANCER TREATMENT

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN IGG4-RELATED DISEASES

ANTIBODIES

ANTI-PD-L1 MONOCLONAL ANTIBODIES AND FUSION PROTEINS WITH INTERLEUKIN-15, INTERLEUKIN-15 RECEPTOR ALPHA, OR INTERLEUKIN-2

METHODS OF TREATING TUMOR

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

CD3 TARGETING ANTIBODIES AND USES THEREOF

DOSAGE REGIMENS FOR ANTI-CD19 AGENTS AND USES THEREOF

CLDN18.2-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF

ANTIBODY AND USE THEREOF

Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody

COMPOSITIONS AND METHODS FOR TREATING MACROPHAGE ACTIVATION SYNDROME

METHODS OF SELECTING, BASED ON POLYMORPHISMS, AN INFLAMMATORY BOWEL DISEASE SUBJECT FOR TREATMENT WITH AN ANTI-TL1A ANTIBODY

ANTIBODY SPECIFICALLY BINDING TO ANGIOPOIETIN-2, OR FRAGMENT THEREOF

PREVENTION OF RESPIRATORY SYNCYTIAL VIRUS LOWER RESPIRATORY TRACT INFECTION WITH NIRSEVIMAB

HYPERIMMUNIZED EGG PRODUCT FOR TREATING OR PREVENTING ALCOHOLIC LIVER DISEASE AND GRAFT-VERSUS-HOST DISEASE

Method for Treating Antibody-Mediated Rejection Post-Transplantation

BLOOD-BRAIN BARRIER TRANSLOCATING PEPTIDES AND RELATED MOLECULES AND METHODS OF USE THEREOF

POLYMER-BASED CONJUGATE, COMPRISING POLYPROPYLENE OXIDE, FOR IMPROVING THERAPEUTIC EFFECTS OF ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES

COMBINATION ANTI-4-1BB IMMUNOTHERAPY, RADIOTHERAPY, AND B CELL ACTIVATION THERAPY

COMBINATION OF CYTOKINE FUSION PROTEINS WITH CD8 ANTIGEN BINDING MOLECULES

MONOMERIC ANNEXIN A5 FOR USE IN THE TREATMENT OF MACULAR OEDEMA OR RETINAL VEIN OCCLUSION

CANCER TREATMENT USING ULTRA-HIGH CONCENTRATION GASEOUS NITRIC OXIDE AND A CHECKPOINT INHIBITOR

METHODS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

ASSESSMENT OF INTESTINAL BARRIER FUNCTION TO IMPROVE TREATMENT OF INFLAMMATORY BOWEL DISEASE

FCRN/ANTIGEN-BINDING MOLECULES AND METHODS OF USE

INTERFERON GAMMA VARIANTS AND ANTIGEN BINDING MOLECULES COMPRISING THESE

PERTUZUMAB PLUS TRASTUZUMAB FIXED DOSE COMBINATION

ACTIVATABLE ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES OF THE SAME

PSMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

MAGEB2 BINDING CONSTRUCTS

BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCT WITH ENHANCED TISSUE DISTRIBUTION

ANTI-CD155 ANTIBODY AND USE THEREOF

MACROPINOCYTOSING HUMAN ANTI-CD46 ANTIBODIES AND TARGETED CANCER THERAPEUTICS

GLYCAN-SHIELDED CD24 EPITOPES AND USES THEREOF

HUMANIZED HH1

COMBINATION TREATMENT OF GLOFITAMAB AND CHEMOTHERAPY

COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES THEREOF

ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES THEREOF

IMMUNOGLOBULIN PROTEINS THAT BIND TO NPR1 AGONISTS

IL10RB BINDING MOLECULES AND ENCODING NUCLEIC ACIDS

COMPOSITIONS AND METHODS RELATED TO IL2 RECEPTOR BINDING

BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES

PLANT-DERIVED THERAPEUTIC MONOCLONAL ANTIBODIES AND THEIR USE IN PREGNANT WOMEN

FUSION PROTEIN OF ANTI-TIGIT ANTIBODY AND IL2 OR VARIANT THEREOF, AND APPLICATION THEREOF

Methods for Manipulating Phagocytosis Mediated by CD47

CLAUDIN 4 AND CLAUDIN 9 ANTIBODIES AND METHODS OF TREATING CANCER

MULTIFUNCTIONAL MOLECULES THAT BIND TO T CELL RELATED CANCER CELLS AND USES THEREOF

ANTI IL-6 DOMAIN ANTIBODIES WITH FATTY ACID SUBSTITUENTS

PREDICTING RESPONSE TO IL-6 ANTAGONISTS

IL-5 ANTIBODY, ANTIGEN BINDING FRAGMENT THEREOF, AND MEDICAL APPLICATION THEREFOR

ANTIGEN BINDING MOLECULE FORMATS

ANTI-FAM19A5 ANTIBODIES AND USES THEREOF

EPO VARIANTS AND MODULATORS

Anti-HSP90 alpha antibody and uses thereof

BROADLY NEUTRALIZING ANTI-SARS-COV-2 ANTIBODIES TARGETING THE N-TERMINAL DOMAIN OF THE SPIKE PROTEIN AND METHODS OF USE THEREOF

BISPECIFIC ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE

Chimeric Antigen Receptors Targeting HER2

TARGETED MODIFIED TNF FAMILY MEMBERS

METHODS FOR TREATING PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

INHIBITION OF HISTONE METHYL TRANSFERASES TO TREAT CANCER

COMBINATION THERAPY FOR CLASSIC HODKIN'S LYMPHOMA

CLAUDIN18.2 HUMANIZED ANTIBODY AND APPLICATION THEREOF

METHOD FOR IDENTIFYING CANCER PATIENTS THAT BENEFIT FROM ANTI-CLEVER-1 TREATMENT

Antibody or Fragment Thereof Binding Specifically to Mertk, and Anti-Tumor Agent

VECTORIZED LANADELUMAB AND ADMINISTRATION THEREOF

BINDING AGENTS TARGETING CD36-EXPRESSING TUMOR CELLS

HUMANIZED ANTI-CD45 ANTIBODIES AND USES THEREOF

ANTI-GLYCO-CD44 ANTIBODIES AND THEIR USES

FORMULATIONS OF HUMAN ANTI-RANKL ANTIBODIES, AND METHODS OF USING THE SAME

ANTI-PDL1 ANTIBODIES, MULTISPECIFIC ANTIBODIES AND METHODS OF USE

METHODS OF TREATING CANCER IN IMMUNOSUPPRESSED OR IMMUNOCOMPROMISED PATIENTS BY ADMINISTERING A PD-1 INHIBITOR

SINGLE-DOMAIN ANTIBODY TARGETING PD-1, DERIVATIVE THEREOF AND USE THEREOF

ANTI-PVRIG ANTIBODIES AND METHODS OF USE

ANTIBODIES AGAINST TIM3 AND USES THEREOF

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

ANTIBODY THAT BINDS TO CANNABINOID TYPE 1 RECEPTORS

USE OF ANTI-CLAUDIN-1 ANTIBODIES TO TREAT CHOLANGIOCARCINOMA

IL31-BINDING POLYPEPTIDES AND USES THEREOF

METHODS FOR TREATING DISEASE USING PSMP ANTAGONISTS

TREATMENT OF OPHTHALMOLOGIC DISEASES

Antibodies Specifically Recognizing Gdf15 and Uses Thereof

USE OF MYOSTATIN INHIBITOR FOR TREATING SPINAL MUSCULAR ATROPHY

POLYPEPTIDES THAT BIND PROANGIOGENIC GROWTH FACTORS

ANTI-FABP4 ANTIBODIES AND THEIR USES

PROCESS FOR PREPARATION OF SECRETORY IgA AND SECRETORY IgM AND USE THEREOF FOR TREATING NECROTIZING ENTEROCOLITIS

PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-HER2 ANTIBODY FOR SUBCUTANEOUS ADMINISTRATION

METHODS OF TREATING AND PREDICTING NON-RESPONSE TO ANTI-TNF TREATMENT IN SUBJECTS WITH GASTROINTESTINAL TRACT DISEASES

HOMODIMER FUSION PROTEINS FOR TREATING ATOPIC DERMATITIS

GLYCOPEPTIDE MEDIATED T CELL IMMUNITY AND ANTI-TUMOR EFFICACY IN CANCER

METHODS FOR TREATING GI SYNDROME AND GRAFT VERSUS HOST DISEASE

BISPECIFIC ANTIGEN BINDING PROTEIN

BISPECIFIC ANTIGEN BINDING MOLECULES COMPRISING ANTI-FAP CLONE 212

ANTI-TNFR2 ANTIBODY AND PREPARATION METHOD AND APPLICATION THEREOF

INTERFERON-ASSOCIATED ANTIGEN BINDING PROTEINS FOR USE FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION

METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY

METHODS OF REDUCING OR HINDERING DEVELOPMENT OF ISCHEMIA-REPERFUSION INJURY DUE TO KIDNEY TRANSPLANTATION WITH AN ANTIBODY THAT INHIBITS GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) SIGNALING

BISPECIFIC DENDRITIC CELL ENGAGER AND USES THEREOF

ANTI-PDL1 ANTIBODIES AND METHODS OF USE

HUMAN PD-L1 ANTIBODIES AND METHODS OF USE THEREFOR

CD8-Binding Polypeptides and Uses Thereof

KIDNEY-GLOMERULAR TARGETED IMMUNOTHERAPY

METHODS FOR TRIGGERING SAFETY KILLING MECHANISMS USING A CD47-SIRPalpha BLOCKADE AGENT

METHOD OF TREATING VITILIGO WITH INTERFERON-GAMMA ANTIBODY

TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF Fab

ANTIBODIES TO PYROGLUTAMATE AMYLOID-B AND USES THEREOF

Novel Molecules for Therapy and Diagnosis

ANTI-ALLERGEN ANTIBODIES AND USES THEREOF

METHODS OF TREATING HIV-1 INFECTION UTILIZING BROADLY NEUTRALIZING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GP120-SPECIFIC MONOCLONAL ANTIBODIES

BROADLY NEUTRALIZING ANTIBODIES THAT TARGET HIV ENV V3 N-GLYCANS

UNGULATE-DERIVED POLYCLONAL IMMUNOGLOBULIN SPECIFIC FOR INFLUENZA VIRUS AND USES THEREOF

ANTIBODIES OR ANTIBODY-FRAGMENTS THEREOF TARGETING ALPHAVIRUSES, AND COMPOSITIONS AND METHODS COMPRISING SAME

D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF

TREATMENT OF CANINE CANCERS

PHEROMONICIN AGAINST SARS-COV-2 AND USE THEREOF

ANTI-LY6H ANTIBODIES AND ANTIBODY DRUG CONJUGATES

MESOTHELIN CHIMERIC ANTIGEN RECEPTOR (CAR) AND ANTIBODY AGAINST PD-L1 INHIBITOR FOR COMBINED USE IN ANTICANCER THERAPY

FUSION PROTEIN CONTAINING ANTI-TIGIT ANTIBODY AND TGF-ßR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING FIBROSIS

ANTI-TUMOR COMBINED PREPARATION COMPRISING HYDROXYPROGESTERONE CAPROATE AND USE THEREOF

MUTANT AND MISLOCALIZED CELL SURFACE NUCLEOPHOSMIN 1 AS A DIAGNOSTIC AND THERAPEUTIC TARGET OF HUMAN DISEASE

ANTIBODIES CAPABLE OF SPECIFICALLY BINDING TL1A AND USE THEREOF

HUMANIZED NON-OPIOID COMPOSITION AND THERAPIES FOR PAIN MANAGEMENT

INHIBITION OF CSF-1 or CSF-1R FOR THE TREATMENT OF MINIMAL RESIDUAL DISEASE

COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

MULTISPECIFIC BINDING AGENTS TARGETING DOPAMINE RECEPTOR D2 AND METHODS OF USE THEREOF

NOVEL ANTI-PD-L1 ANTIBODIES

TREATMENT AND PREVENTION OF CANCER USING VISTA ANTIGEN-BINDING MOLECULES

ANTI-LAG3 ANTIBODIES

BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING CD19 AND CD3, AND USES THEREOF

RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 1 (ROR1)-SPECIFIC VHH ANTIBODIES AND MULTISPECIFIC ANTIBODIES THEREOF AS IMMUNE CELL ENGAGERS

ANTI-CD200R1 ANTIBODIES

NOVEL ANTI-LAG3 ANTIBODIES

DLL3 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC COMPOSITIONS THEREOF

ANTI-PAR2 ANTIBODIES

NOVEL CYTOKINE-BASED THERAPIES AND METHODS

RISANKIZUMAB COMPOSITIONS

Methods of treating giant cell arteritis using Interleukin-17 (IL-17) Antagonists

MODULATION OF WNT SIGNALLING IN OCULAR DISORDERS

COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES

SARBECOVIRUS SPIKE S2 SUBUNIT BINDERS

FUSION PROTEIN OF RELAXIN OR ANALOGUE AND MEDICAL USE THEREOF

ANTITUMOR BACTERIAL STRAIN, AND COMPOSITION AND METHOD USING SAME

Germinal Center Response to Engineered Bacteria Promotes Bladder Cancer Immunotherapy

METHODS AND COMPOSITIONS COMPRISING A SHP2 INHIBITOR AND A PD-LI BINDING ANTAGONIST

ANTIBODY-DRUG CONJUGATES AND USES THEREOF

Methods for Prognosing Type 1 Diabetes Treatments

THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER

EXPRESSION OF NOVEL CELL TAGS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

MODIFIED FC PROTEINS COMPRISING SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, CONJUGATES OF THE SAME, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE

V.kappa.4-1-IGLC Polypeptide and Use Thereof

HER2 SINGLE DOMAIN ANTIBODY AND USES THEREOF

COMPOSITIONS AND METHODS FOR UPREGULATING HLA CLASS I ON TUMOR CELLS

Methods and Compositions for Treating Obesity, Obesity-Related Diseases, Fatty Liver and Fatty Liver Associated Diseases with Anti-CD24 Agents

MULTISPECIFIC BINDING MOLECULES AND METHODS OF USE THEREOF

HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR

NK ENGAGER MOLECULES AND METHODS OF USE THEREOF

ANTI-BLOOD DENDRITIC CELL ANTIGEN 2 ANTIBODIES AND USES THEREOF

PROTEOLYTICALLY CLEAVABLE CHIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF

ANTI-BTLA ANTIBODIES AND USES THEREOF IN TREATING CANCER

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20

ANTI-HEMOJUVELIN (HJV) ANTIBODIES FOR TREATING MYELOFIBROSIS

A METHOD OF TREATING SOLID TUMOR

COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC HEART DISEASE

METHODS FOR TREATING SPINAL CORD INJURY AND PAIN

ANTIBODIES TO AMYLOID BETA

ANTI-COMPLEMENT FACTOR H ANTIBODIES

DECREASING STAPHYLOCOCCUS AUREUS INFECTIONS IN COLONIZED PATIENTS

ANTIBODIES WITH NOVEL FC MODIFICATION COMBINATIONS THAT INCREASE ANTIBODY FUNCTION

HALF-LIFE EXTENDED IMMTAC BINDING CD3 AND A HLA-A*02 RESTRICTED PEPTIDE

ENHANCING NON-VIRAL DNA DELIVERY AND EXPRESSION

METHOD OF TREATING INFLUENZA A

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS D VIRUS (HDV) INFECTION AND ASSOCIATED DISEASES

COMBINATION OF VACCINATION AND OX40 AGONISTS

POSTBIOTIC-BASED COMPOSITION FOR THE TREATMENT OF TUMORS

TREATMENT OF METABOLIC SYNDROME AND ASSOCIATED MORBIDITIES USING INTESTINAL TH17 CELLS OR INTESTINAL TH17 CELL-DERIVED MOLECULES

PHARMACEUTICAL COMPOSITION COMPRISING SUTTERELLA WADSWORTHENSIS AND IMMUNE CHECKPOINT INHIBITORS FOR TREATMENT OF COLON CANCER

DISRUPTION OF EPITHELIAL BARRIERS FOR MOLECULAR DELIVERY ENHANCEMENT OR EXTRACTION OF EXTRACELLULAR FLUIDS

HUMAN FC VARIANTS HAVING IMPROVED FCGRIIA BINDING SELECTIVITY

TREATMENT OF RENAL CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT

ANTIBODIES TO CANCER GLYCOSYLATION AND USES THEREOF

THERAPEUTIC ANTIBODIES

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

COMPOSITIONS AND USES OF TUMOR ACTIVATED ANTIBODIES TARGETING EGFR AND EFFECTOR CELL ANTIGENS

HLA-G-SPECIFIC ANTIBODY AND USE THEREOF

Anti-B7-H4 Antibodies and Immunoconjugates

MULTIFUNCTIONAL MOLECULES BINDING TO TCR AND USES THEREOF

PREPARATIONS CONTAINING ANTI-CLAUDIN18.2/CD3 BISPECIFIC ANTIBODY, PREPARATION METHOD THEREFOR AND USE THEREOF

TARGETED ANTI-SGLT1 AVIAN IGY ANTIBODIES AS TREATMENT OF PRE-DIABETES, TYPE 2 DIABETES AND GESTATIONAL DIABETES

ANGIOPOIETIN-RELATED PROTEIN 7-SPECIFIC ANTIBODIES AND USES THEREOF

ANTIGEN BINDING PROTEIN AND USES THEREOF

PRECISION ACTIVATED POLYPEPTIDES

COMBINATION THERAPY

RSV/HMPV CROSS-REACTIVE ANTIBODIES

ENGINEERED POLYPEPTIDES

THERAPEUTIC AND DIAGNOSTIC AGENTS AND USES THEREOF

IgY Antibody Compositions and Methods for Treating Mammal Species

ENGINEERED POLYPEPTIDES AND USES THEREOF

EXOSOMES FOR IMMUNO-ONCOLOGY AND ANTI-INFLAMMATORY THERAPY

METHODS FOR TREATMENT USING ANTI-ALPHA4BETA7 ANTIBODY

METHODS OF TREATING AUTOIMMUNE AND ALLOIMMUNE DISORDERS

DRUG COMBINATION FOR TREATING NON-SMALL CELL LUNG CANCER

METHODS OF TREATING LOCALLY ADVANCED OR METASTATIC BREAST CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

COMBINATION OF LURBINECTEDIN AND IMMUNE CHECKPOINT INHIBITORS

METHODS AND SYSTEMS FOR SELECTION AND TREATMENT OF PATIENTS WITH INFLAMMATORY DISEASES